BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Bionano Genomics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$1.22−0.03 (-2.40%)
Close on Oct 19, 2026
- Market cap
- $14.09M
- P/E (TTM)
- –
- Dividend yield
- –
Bionano Genomics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Laboratory Analytical Instruments companies for comparison
Valuation
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Market Cap | $14.37M | $230.55M |
| Enterprise Value | $4.45M | $202.97M |
| PS Ratio | 0.48 | 3.11 |
| PB Ratio | 0.45 | 3.14 |
| P/TBV Ratio | 0.48 | 4.57 |
Enterprise value
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| EV / Sales | 0.15 | 2.92 |
Income (trailing twelve months)
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Revenue | $30.18M | $102.39M |
| Gross Profit | $14.34M | $60.36M |
| Operating Income | -$32.19M | -$4.31M |
| Pretax Income | -$32.10M | -$2.26M |
| Net Income | -$32.16M | -$6.57M |
| EBITDA | -$22.87M | -$1.98M |
| EPS (Diluted) | -$3.76 | -$0.07 |
Margins
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Gross Margin | 47.5% | 55.1% |
| Operating Margin | -106.7% | -6.04% |
| Pretax Margin | -106.4% | -4.11% |
| Profit Margin | -106.6% | -10.5% |
| EBITDA Margin | -75.8% | -2.67% |
Returns
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Return on Equity (ROE) | -83.6% | -19.2% |
| Return on Assets (ROA) | -52.0% | -13.3% |
| Return on Invested Capital (ROIC) | -100.5% | -4.11% |
| Return on Capital Employed (ROCE) | -85.7% | -9.07% |
Growth
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 10.0% | 8.85% |
| Revenue Growth (3Y CAGR) | 0.84% | 7.08% |
| Revenue Growth (5Y CAGR) | 27.4% | 11.8% |
Balance sheet
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $9.92M | $37.33M |
| Net Cash (Debt) | $9.92M | $3.92M |
| Net Cash Per Share | $0.84 | $0.28 |
| Equity (Book Value) | $31.61M | $57.36M |
| Book Value Per Share | $2.68 | $2.81 |
| Tangible Book Value | $29.94M | $10.71M |
| Working Capital | $14.84M | $54.64M |
Financial position
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Current Ratio | 2.48 | 2.50 |
| Quick Ratio | 1.42 | 1.54 |
Cash flow (trailing twelve months)
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Operating Cash Flow | -$20.48M | -$653.46K |
Efficiency
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Asset Turnover | 0.49 | 0.59 |
| Inventory Turnover | 1.83 | 2.21 |
| Revenue Per Employee | $311.09K | $322.57K |
| Profits Per Employee | -$331.57K | -$51.88K |
| Employee Count | 97 | 185 |
Dividends and yields
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Earnings Yield | -223.8% | -6.91% |
| Buyback Yield | -111.5% | 0.78% |
| Shareholder Yield | -111.5% | 0.80% |
Shares
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Shares Outstanding | 11,777,000 | 44,856,700 |
| Shares Change (YoY) | 314.2% | 3.35% |
| Shares Change (QoQ) | 4.44% | 0.27% |
| Float | 11,566,600 | 37,097,900 |
| Shares Held by Insiders | 1.79% | 10.6% |
| Shares Held by Institutions | 6.02% | 63.5% |
Taxes
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Income Tax | $66.00K | $1.52M |
Scores
| Measure | Bionano Genomics | Industry median |
|---|---|---|
| Altman Z-Score | -22.32 | 1.95 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -3.45 | -2.64 |
Calculated by StockData from Bionano Genomics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.